Literature DB >> 3987812

Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.

K H Sanders, I Jurna.   

Abstract

The influence of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity was determined in anaesthetized cats and rats. The effects of these drugs on blood pressure and heart rate were also evaluated. Impulse output was recorded in the splanchnic and vagus nerve of the cat, and in the cervical sympathetic trunk of the rat. Urapidil increased activity in sympathetic and parasympathetic nerve fibres in cats at low doses without affecting blood pressure and heart rate. At higher doses which lowered blood pressure, urapidil reduced sympathetic impulse output in cats and rats while vagal output was increased. The alpha 1-adrenoceptor blocking agent, prazosin, did not affect activity in sympathetic and parasympathetic nerve fibres while the beta-adrenoceptor blocking agent, propranolol, increased activity in these nerves in cats. The alpha-adrenoceptor agonist, clonidine, reduced sympathetic impulse output at all doses tested in both rats and cats. The results provide evidence that urapidil, in addition to its peripheral alpha- and beta-adrenoceptor blocking properties, affects cardiovascular regulation by a central action. Blockade of alpha- or beta-adrenoceptors in the brain is probably not responsible for the central effect of urapidil.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987812     DOI: 10.1016/0014-2999(85)90210-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Experimental studies on the neurocardiovascular effects of urapidil.

Authors:  R A Gillis; K J Kellar; J A Quest; I J Namath; A Martino-Barrows; K Hill; P J Gatti; K Dretchen
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Proceedings of the British Pharmacological Society. 17th-19th December 1986. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

Review 3.  Human pharmacology of urapidil.

Authors:  A M Shepherd
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Effect of urapidil on the performance of ischemic myocardium in anesthetized dogs.

Authors:  H Schad; W Heimisch; A Barankay; S Hesse; N Mendler
Journal:  Basic Res Cardiol       Date:  1990 May-Jun       Impact factor: 17.165

Review 5.  Amitraz poisoning, an emerging problem: epidemiology, clinical features, management, and preventive strategies.

Authors:  H L Yilmaz; D R Yildizdas
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

6.  Acute haemodynamic effects of urapidil in patients with chronic left ventricular failure.

Authors:  U Tebbe; W Wurst; K L Neuhaus
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors.

Authors:  A G Ramage
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 8.  Clinical pharmacokinetics of urapidil.

Authors:  R Kirsten; K Nelson; V W Steinijans; K Zech; R Haerlin
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

9.  Differential effects of centrally-active antihypertensives on 5-HT1A receptors in rat dorso-lateral septum, rat hippocampus and guinea-pig hippocampus.

Authors:  D J Leishman; P H Boeijinga; M Galvan
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

Review 10.  Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H D Langtry; G J Mammen; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.